XNAS: KYTX
Kyverna Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made...
Read More
9.57
-1.17
(-10.89%)
481.6K
XNAS Volume
XNAS 15 May, 2026 12:44 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Kyverna Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..